Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority Study of the Molecular Imaging of Dopamine Transporters Using [123I]-FP/CIT-SPECT and [18F] LBT-999-PET to Distinguish Between Parkinson's Disease and Essential Tremor.

NCT04265209 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT04265209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04265209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority Study of the Molecular Imaging of Dopamine Transporters Using [123I]-FP/CIT-SPECT and [18F] LBT-999-PET to Distinguish Between Parkinson's Disease and Essential Tremor.
Lead sponsor
GE Healthcare
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2021
Completion date
August 2, 2024
Enrollment
152 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

essential tremor, parkinson disease